Net earnings were $250 million, or 22 cents a share, in the fiscal fourth quarter ended in April. That compared with $812 million, or 72 cents a share, in the same period a year earlier.
Excluding special items, the world's largest stand-alone medical device maker reported a profit of 82 cents a share, up 5 percent from a year ago and matching Wall Street estimates.
Fourth-quarter revenue fell 1 percent to $3.83 billion.
(Reporting by Susan Kelly; Editing by Derek Caney)